First Trust Advisors’s Cardlytics CDLX Stock Holding History

First Trust Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,161	Closed	-$203K	–	2437
2022 Q3	$203K	Buy	+2,161	New	+$308K	﹤0.01%	2404
2021 Q4	–	Sell	-405	Closed	-$340K	–	2522
2021 Q3	$340K	Sell	405 -113	-22%	-$115K	﹤0.01%	2361
2021 Q2	$658K	Sell	518 -5,720	-92%	-$6.46M	﹤0.01%	2182
2021 Q1	$6.84M	Sell	6,238 -95	-2%	-$125K	0.01%	1080
2020 Q4	$9.04M	Sell	6,333 -829	-12%	-$884K	0.01%	869
2020 Q3	$5.05M	Sell	7,162 -133	-2%	-$96.7K	0.01%	960
2020 Q2	$5.11M	Buy	+7,295	New	+$4.21M	0.01%	974

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

GEH

General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

First Trust Advisors's CDLX Position: Q4 2022 in Review

First Trust Advisors sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 2,161 shares — an estimated $203K sold.

First Trust Advisors first reported a position in CDLX in Q2 2020 and held it in 7 quarters. The position peaked at $9.04M in Q4 2020. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

First Trust Advisors reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
First Trust Advisors sold 2,161 Cardlytics shares in Q4 2022, an estimated $203K.
First Trust Advisors first reported a position in Cardlytics in Q2 2020 and held it in 7 quarters.
First Trust Advisors's Cardlytics position peaked at $9.04M in Q4 2020.
121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.